Alpine Immune Sciences Inc expected to post a loss of 27 cents a share - Earnings Preview

Alpine Immune Sciences

21/03/2023 21:10

* Alpine Immune Sciences Inc  ALPN.OQ   ALPN.O  is expected
to show a rise in quarterly revenue when it reports  results on
March 23. 
    * The Seattle Washington-based  company is expected to
report  a
142.0% increase in revenue to $10.964 million from $4.53 million
a year ago, according to the mean estimate from 5 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Alpine Immune
Sciences
Inc is for a loss of 27 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Alpine
Immune
Sciences Inc is $16​, above​ its last closing price of $8.01.
​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  -0.02       -0.10      -0.42     Missed  -309.8
 Jun. 30 2022  -0.46       -0.39      -0.60     Missed  -52.9
 Mar. 31 2022  -0.27       -0.19      -0.25     Missed  -33.3​
 Dec. 31 2021  -0.43       -0.30      -0.52     Missed  -70.5
 ​​Sep.        0.17        0.01       -0.55     Missed  -11,10
 30 2021                                                0
 Jun. 30 2021  -0.37       -0.40      -0.46     Missed  -16.2​
 Mar. 31 2021  -0.36       -0.36      -0.45     Missed  -26.2
 Dec. 31 2020  -0.26       -0.31      -0.27     Beat    13.4
 This summary was machine generated March 21 at 21:10 GMT.  All
figures in US dollars  unless otherwise stated